Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

The deadline for the WBC2016 Legacy Travel Award has been extended to March 2, 2026, to match the abstract deadline extension for the CBS CSPS CC-CRS Conference...

Dear members and friends of the Canadian Biomaterials Society, The abstract deadline has been extended to March 2nd, 2026 for the upcoming CBS CCPS cc-CRS 2026 meeting this June in Vancouver, BC...

Dear friends , For this years annual meeting in beautiful Vancouver, BC June 2 - 5 2026 we are happy to partner with the Canadian Society for Pharmaceutical Sciences CSPS and the Canadian Chapter of the Controlled Release Society cc-CRS ...

Call for Abstracts is OPEN The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...

Liver cancer is the sixth most common cancer, and the second leading cause of cancer death1. The majority of liver cancer cases are hepatocellular carcinoma HCC ...

Bone metastases have been treated by several methods including surgery and chemotherapy. One treatment by surgery involves removal of cancerous bone and implantation of a scaffold or graft to fill the void and to allow new bone formation...

Metal by-products, including metal ions, released in greater amount from metal-on-metal MM hip implants than from metal-on-polyethylene implants are a cause for concern as they can compromise the functionality and survivorship of the implants due to adverse tissue reactions 1, 2 ...

Revascularization approaches that involve delivering growth factors with short half-lives minutes over periods of weeks in order to regenerate micro vessels have been identified as promising strategies to address disorders related to compromised tissue perfusion...

Cardiovascular diseases are one of the leading causes of mortality worldwide. When the replacement of diseased arteries is needed, vascular surgeons often have no choice but to use synthetic arterial prostheses made either of poly ethylene terephthalate PET or Dacron or expanded tetrafluoroethylene ePTFE or Teflon ...